Related Experiment Video
Updated: Aug 12, 2026

Labeling Stem Cells with Ferumoxytol, an FDA-Approved Iron Oxide Nanoparticle
Published on: November 4, 2011
Arabinogalactan-coated superparamagnetic iron oxide: effect of particle size in liver MRI
E R Wisner1, E G Amparo, D R Vera
1Department of Radiology, School of Medicine, University of California, Davis 95817.
Objective:
We evaluated the effect of particle size on MR contrast-enhancing properties of arabinogalactan-coated superparamagnetic iron oxide (AG-SPIO) in tumor-bearing rats.
Materials And Methods:
T2*-weighted gradient-recalled echo MR studies were performed on rats with surgically implanted liver tumors before and after AG-SPIO administration. Contrast-to-noise ratio (CNR) and percent contrast enhancement (PCE) were calculated for animals given small (15.7 +/- 9.5 nm: n = 6), medium (49.1 +/- 19.7 nm; n = 4), and large (86.9 +/- 27.5 nm; n = 4) particles intravenously (10 mumol Fe/kg).
Results:
Postcontrast CNRs were 15.8 +/- 6.9, 8.9 +/- 4.1, and 10.0 +/- 1.8 for small, medium, and large particle groups, respectively. The PCE was -60.0 +/- 3.3, -75.5 +/- 7.9, and -80.5 +/- 1.2%. There was a significant difference in preversus postcontrast CNR for all particle sizes (p < 0.001) and in PCE for small particles as compared with the two larger sizes (p < 0.001). There was no between-group statistical difference in postcontrast CNR for any particle size.
Conclusion:
Larger AG-SPIO particles slightly improve liver contrast enhancement, but have no significant effect on hepatic lesion detection as assessed by CNR.
Insights
Particle size impacts arabinogalactan-coated superparamagnetic iron oxide (AG-SPIO) contrast enhancement in liver tumors. Larger AG-SPIO particles slightly improve enhancement but do not significantly affect lesion detection by CNR.
Area of Science:
- Biomedical Engineering
- Materials Science
- Radiology
Background:
- Superparamagnetic iron oxide nanoparticles (SPIONs) are used as MRI contrast agents.
- Arabinogalactan coating (AG-SPIO) influences nanoparticle properties.
- Particle size is a critical factor in SPION performance.
Purpose of the Study:
- To evaluate the effect of AG-SPIO particle size on MR contrast enhancement in liver tumors.
- To determine if particle size influences hepatic lesion detection using CNR.
Main Methods:
- T2*-weighted gradient-recalled echo MR imaging was performed on tumor-bearing rats.
- Rats received intravenous AG-SPIO with small (15.7 nm), medium (49.1 nm), or large (86.9 nm) particle sizes.
- Contrast-to-noise ratio (CNR) and percent contrast enhancement (PCE) were calculated.
Main Results:
- All particle sizes significantly improved CNR post-administration (p < 0.001).
- Larger AG-SPIO particles showed significantly higher PCE compared to smaller particles (p < 0.001).
- No significant difference in postcontrast CNR was observed between different particle sizes.
Conclusions:
- Larger AG-SPIO particles offer a slight improvement in liver contrast enhancement.
- Particle size did not significantly impact hepatic lesion detection as measured by CNR.
- Further research may explore optimal AG-SPIO characteristics for enhanced tumor imaging.
Related Concept Videos
Magnetic Resonance Imaging
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...

